http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100632800-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-84
filingDate 2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100632800-B1
titleOfInvention Novel hydroxyamide derivatives having histone deacetylase inhibitory activity and preparation method thereof
abstract The present invention relates to a novel hydroxyamide derivative compound of Formula 1 or a pharmaceutically acceptable salt thereof, a method for preparing the same, and an anticancer composition containing the same, wherein the novel compound of Formula 1 is an anticancer agent and histone diacetyl It can be usefully used as a prophylactic and therapeutic agent for various diseases caused by the enzymatic activity of histone deacetylase.n n n <Formula 1>n n n n n n n n Wheren n n A is C═O or CH 2 ,n n n R 1 is a phenyl group substituted or unsubstituted with hydroxy, C 1-5 alkyl, C 1-5 alkyloxy, aryl oxy, aryl amino, C 1-5 alkylamino, cyano, cyanophenyl; Naphthyl group; Halogen, C 1-5 alkyl, C 1-5 alkyloxy, C 1-5 alkylamino, C 1-5 alkylaminooxy, C 1-5 alkylarylamino, C 1-5 alkylaryloxyamino or arylmercapto A substituted or unsubstituted, heteroaryl group containing nitrogen, sulfur or oxygen in the ring, wherein the heteroaryl group is piperazine, triazole, thiazole, benzothiazole, dibenzofuran, pyridine, quinoline, or iso Quinoline;n n n R 2 is a hydroxyamino group.
priorityDate 2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100519010-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002065282-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467163039

Total number of triples: 16.